Universe Pharmaceuticals Inc

Universe Pharmaceuticals Inc

Universe Pharmaceuticals Inc is a China-based holding company mainly engaged in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives (TCMD) products targeting the elderly. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The Company mainly conducts its businesses within the Chinese market.

Stock Performance Snapshot

Above Average

Financial Health

Universe Pharmaceuticals is generating good revenue and cash flow, showing a solid financial position.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Baskets Featuring UPC

China's Biopharma Innovators: The Next Global Partnership Wave

China's Biopharma Innovators: The Next Global Partnership Wave

Following GSK's major licensing deal with China's Jiangsu Hengrui, a new investment theme is emerging around Chinese pharmaceutical innovators. This theme focuses on other Chinese biopharma companies that are likely to attract similar global partnerships, driving value through their advanced drug development pipelines.

Published: July 28, 2025

Explore Basket

Why You’ll Want to Watch This Stock

📈

Tiny market cap

At roughly $3M market value, UPC is a microcap — movements can be large and trading thin, so price swings may be rapid and unpredictable.

Pipeline & regulation

Pharmaceutical value often hinges on clinical and regulatory milestones; positive data can lift sentiment, but failures can be costly.

🌍

Liquidity & news

With limited publicly available information, news and filings can drive big moves; perform careful due diligence and be aware of dilution risk.

Why invest with Nemo?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Frequently asked questions